肝纤维化程度无创技术评估进展

高永艳 综述 梁 萍 审校

武警医学 ›› 2016, Vol. 27 ›› Issue (5) : 513-515.

PDF(725 KB)
PDF(725 KB)
武警医学 ›› 2016, Vol. 27 ›› Issue (5) : 513-515.
综述

肝纤维化程度无创技术评估进展

  • 高永艳1,2 综述 梁 萍1 审校
作者信息 +
文章历史 +

摘要

中国是世界肝炎患病率最高的国家之一,以乙型肝炎(hepatitis B virvs,HBV)为多,据2006年国家卫生局统计,9.75%的1~59岁普通人群携带乙肝病毒[1]。慢性肝炎、肝纤维化、肝硬化、肝癌是疾病自然病程发展的必然趋势。近年来发现,对肝纤维化的有效治疗可以保护肝功能,甚至使纤维化逆转[2],从而有效防控病程的发展,降低患者发生肝硬化肝癌的风险。评价肝纤维化的金标准为肝组织学穿刺活检,但具有创伤性小、取材少、病理评价受主观因素影响等不足。笔者就无创技术评估肝纤维化程度的进展进行综述。

关键词

血清学评价技术 / 弹性成像技术 / 肝纤维化

引用本文

导出引用
高永艳 综述 梁 萍 审校. 肝纤维化程度无创技术评估进展[J]. 武警医学. 2016, 27(5): 513-515
中图分类号: R657.31   

参考文献

[1] Ministry of Health, China. National Plan for Prevention and Treatment against Hepatitis B for 2006-10.
[2] 郭 蓉,阎 明. 肝纤维化的细胞和分子机制研究进展[J]. 中国肝脏病杂志: 电子版,2012,4(4) : 57-62
[3] Wai C T, Greenson J K, Fontana R J, et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C[J].Hepatology, 2003, 38( 2): 518-526.
[4] Güzelbulut F, Sez1kl1 M,Akkan-et1nkaya Z, et al. AST-platelet ratio index in the prediction of significant fibrosis and cirrhosis in patients with chronic hepatitis B[J]. Turk J Gastroenterol,2012,23(4):353-358.
[5] Ray K W,Berg T, Asselah T, et al. Evaluation of APRI and FIB-4 scoring systems for non-invasive assessment of hepatic fibrosis in chronic hepatitis B patients[J]. J Hepatol,2015:25.
[6] Ito T,Kumada T,Toyoda H,et al. FIB-4 index for assessing the prognosis of hepatocellular carcinoma in patients with Child-Pugh class A liverfunction[J]. J Cancer Res Clin Oncol,2015,141(7):1311-1319.
[7] WHO, Guidelines for the prevention, care and treatment of persons with chronic hepatitis B Infection. Geneva: World Health Organization, 2015.
[8] Sterling R K,Lissen E,Clumeck N,et al.Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection[J].Hepatology,2006,43 (6): 1317-1325.
[9] Imbert B F, Rarziu V, Pieroni L, et al.MULTIVIRC Group. Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study[J]. Lacent, 2001,357(9262):1069-1075.
[10] Fraquelli M, Rigamonti C, Casazza G, et al. Reproducibility of transient elastography in the evaluation of liver brosis in patients with chronic liver disease[J]. Gut, 2007,56(7):968-973.
[11] Cheng J, Hou J, Ding H, et al. Validation of Ten Noninvasive Diagnostic Models for Prediction of Liver Fibrosis in Patients with Chronic Hepatitis B[J]. PLoS One,2015,10(12):14425.
[12] Zhu X,Wang L C,Chen E Q, et al. Prospective evaluation of FibroScan for the diagnosis of hepatic fibrosis compared with liver biopsy/AST platelet ratio index and FIB-4 in patients with chronic HBV infection[J]. Dig Dis Sci,2011,56(9):2742-2749.
[13] Ziol M, Handra-Luca A, Kettaneh A, et al. Noninvasive assessment of liver brosis by measurement of stiffness in patients with chronic hepatitis C[J]. Hepatology, 2005,41(1):48-54.
[14] Goyal R,Mallick S R,Mahanta M, et al. Fibroscan can avoid liver biopsy in Indian patients with chronic hepatitis B[J]. J Gastroenterol Hepatol,2013,28(11):1738-1745.
[15] Gaia S, Carenzi S, Barilli A L, et al.Reliability of tran-sient elastography for the detection of fibrosis in non alcoholic fatty liver disease and chronic viral hepatitis[J]. J Hepatol,2011,54(1): 64-71.
[16] Shi K Q,Fan Y C,Pan Z Z, et al. Transient elastography: a meta-analysis of diagnostic accuracy in evaluation of portal hypertension in chronic liver disease[J]. Liver Int,2013,33(1):62-71.
[17] Li C, Zhang J Y, Zhang X Y, et al. FibroScan predicts ascites after liver resection for hepatitis B virus-related hepatocellular carcinoma: A prospective cohort study[J]. Int J Surg, 2015,20:21-25.
[18] Shin S H, Kim S U, Park J Y, et al. Liver stiffness-based model for prediction of hepatocellular carcinoma in chronic hepatitis B virus infection: comparison with histological fibrosis[J].Liver Int, 2015,35(3):1054-1062.
[19] Sporea I, Sirli R, Bota S, et al. Is ARFI elastography reliable for predicting fibrosis severity in chronic HCV hepatitis? [J] World J Radiol, 2011,3(7):188-193.
[20] Friedrich-Rust M, Nierhoff J, Lupsor M, et al. Performance of acoustic radiation force impulse imaging for the staging of liver fibrosis: a pooled Meta-analysis[J]. J Viral Hepat, 2012, 19(2):e212-e219.
[21] Suh C H,Kim S Y,Kim, et al. KW Determination of normal hepatic elasticity by using real-time shear-wave elastography[J]. Radiology,2014,271(3):895-900.
[22] Ferraioli G, Tinelli C, Dal Bello B, et al. Accuracy of real-time shear wave elastography for assessing liver fibrosis in chronic hepatitis C: a pilot study[J]. Hepatology, 2012,56(6):2125-2133.
[23] Gerber L, Kasper D, Fitting D, et al. Assessment of liver fibrosis with 2-D shear wave elastography in comparison to transientelastography and acoustic radiation force impulse imaging in patients with chronic liver disease[J]. Ultrasound Med Biol, 2015,41(9):2350-2359.

PDF(725 KB)

Accesses

Citation

Detail

段落导航
相关文章

/